An FDA panel voted 7-2 that the Galleri cancer blood test’s benefits outweigh its risks, but split 6-4 on effectiveness. What it means for adults 50 and older.
FDA Advisers Back Multi-Cancer Blood Test for Adults 50 and Up but Split 6 to 4 on Effectiveness
by | Sep 24, 2026 | Uncategorized | 0 comments
Recent Comments